Early research (Phase 1)Study completedNCT00414336
What this trial is testing
Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 150